| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.35B | +10.1% |
| Cost of Revenue | $257.8M | -3.1% |
| Gross Profit | $1.10B | +13.8% |
| R&D Expense | $281.2M | +2.4% |
| SG&A Expense | $210.4M | +16.4% |
| Operating Income | $302.1M | +31.1% |
| Interest Expense | $17.0M | -51.5% |
| Pre-tax Income | $293.1M | +59.7% |
| Income Tax | $58.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.0M | -6.4% |
| Current Assets | $442.1M | +5.4% |
| Total Assets | $3.40B | +2.4% |
| Current Liabilities | $814.3M | +7.1% |
| Long-term Debt | $1.39B | -9.2% |
| Total Liabilities | $2.36B | -3.2% |
| Stockholders' Equity | $1.04B | +17.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $435.3M | +4.5% |
| Capital Expenditures | $14.0M | -43.8% |
| Investing Cash Flow | -$143.3M | -136.8% |
| Financing Cash Flow | -$289.9M | +19.3% |
| Free Cash Flow | $421.2M | +7.5% |
| +141.0% |
| Net Income | $234.8M | -28.2% |
| EPS (Basic) | $0.75 | -28.6% |
| EPS (Diluted) | $0.72 | -28.0% |